Arkema Closes Acquisition of 54% Stake in PI Advanced Materials

On Dec. 1, 2023, French chemicals and materials company Arkema has finalized the acquisition of Glenwood Private Equity’s 54% – based on a €728 million enterprise value – stake in South Korean company PI Advanced Materials (PIAM). Arkema said in a statement that this acquisition acquisition – first announced last June – complements its portfolio of high-performance technologies for the high-growth markets of advanced electronics and electric mobility.

With more than 30% market share, PIAM, headquartered in Seoul, is the global leader of polyimide films used in the high-growth and high value-added markets of mobile devices and electric vehicles.

According to Arkema, PIAM sales are expected to grow by around 13% per year in the coming years, driven by new cutting-edge applications in 5G antennas, high-resolution OLED displays, flexible screens and electric vehicles, and supported by recent capacity expansions.

Arkema said that PIAM's portfolio, which will strengthen its own range of high-performance polymers, combined with the perfect geographic fit with the group, should enable the French group to achieve synergies estimated at €30 million in terms of EBITDA over the next five years.

© 2016 bluebay/Shutterstock
© 2016 bluebay/Shutterstock

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.